Inactive Instrument

Algeta ASA

Equities

ALGETA

NO0010239437

Biotechnology & Medical Research

Rights Issue: 0.04722 new shares @ 143 NOK for 1 existing share

February 13, 2012

MarketScreener.com By

Rights Issue: 0.04722 new shares @ 143 NOK for 1 existing share

© Factset - 2012

Latest news about Algeta ASA

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14	RE
Actavis : M&A frenzy in healthcare sector	06/05/14	RE
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24/03/14	RE
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24/02/14	RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13	RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13	RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta	26/11/13	RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta	26/11/13	RE
Bayer AG : Bayer says does not want to provide details on Algeta offer	26/11/13	RE

Chart Algeta ASA

Duration

Period

Chart Algeta ASA

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+9.99%	115B
REGENERON PHARMACEUTICALS, INC.	+12.01%	106B
BIONTECH SE	-3.07%	24.69B
ARGENX SE	-0.67%	21.97B
GENMAB A/S	-4.69%	19.27B
BEIGENE, LTD.	-6.90%	17.56B
WUXI APPTEC CO., LTD.	-39.36%	17.32B
NEUROCRINE BIOSCIENCES, INC.	+5.82%	14.03B
SAREPTA THERAPEUTICS, INC.	+33.05%	12.13B

Bio Therapeutic Drugs

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer